FindTrial
Sign In

The mechanism of PECAM-1 in mediating pulmonary vascular endothelial permeability through Wnt/ß-catenin signaling pathway in SARS-CoV-2-related ARDS

The mechanism of PECAM-1 in mediating pulmonary vascular endothelial permeability through Wnt/ß-catenin signaling pathway in SARS-CoV-2-related ARDS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033699
Enrollment
Unknown
Registered
2020-06-09
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory and Critical Medicine

Interventions

Mild group:nil
Moderate group:nil
Severe group:nil
Critical group:nil

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the Department of critical medicine; 2. Patients diagnosed with COVID-19.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 years old; 2. pregnant or lactating women; 3. The patients themselves or their relatives do not agree to join the study.

Design outcomes

Primary

MeasureTime frame
sPECAM-1;—

Countries

China

Contacts

Public ContactXiaoqing Liu

The First Affiliated Hospital of Guangzhou Medical University

lxq1118@126.com+86 13602769670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026